...
首页> 外文期刊>Cellular reprogramming >MiR-142-5p Suppresses Lung Cancer Cell Metastasis by Targeting Yin Yang 1 to Regulate Epithelial-Mesenchymal Transition
【24h】

MiR-142-5p Suppresses Lung Cancer Cell Metastasis by Targeting Yin Yang 1 to Regulate Epithelial-Mesenchymal Transition

机译:miR-142-5p通过靶向阴阳1来调节上皮间充质转换来抑制肺癌细胞转移

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

This study aimed to investigate the mechanism of miR-142-5p and Yin Yang 1 (YY1) on regulating epithelial-mesenchymal transition (EMT) in lung cancer cell metastasis. The expressions of YY1 and miR-142-5p in different lung cancer cell lines were negatively correlated. The results of the dual-luciferase reporter assay further validated that miR-142-5p directly targeted YY1. Subsequently, transwell assays, wound-healing assay, and transplantation tumor model in nude mice proved that YY1 could promote the metastasis of lung cancer cells, whereas miR-142-5p impaired the stimulating effect of YY1 on the metastasis ability of lung cancer cells in vitro and in vivo. Western blot and quantitative real-time polymerase chain reaction analysis of the EMT-related proteins indicated that YY1 could enhance the metastasis ability of lung cancer cells by promoting EMT. On the contrary, miR-142-5p constrained the expression of mesenchymal markers by targeting YY1, reversed the differentiation of cells into mesenchymal cells, and weakened the metastasis ability of tumor cells in vitro and in vivo. In summary, miR-142-5p may regulate the expressions of EMT-related proteins by targeting YY1, thereby inhibiting lung cancer metastasis, which provides a promising therapeutic target for lung cancer.
机译:本研究旨在探讨miR-142-5p和阴阳1(YY1)在肺癌细胞转移中调节上皮-间充质转化(EMT)的机制。YY1和miR-142-5p在不同肺癌细胞系中的表达呈负相关。双荧光素酶报告分析的结果进一步验证了miR-142-5p直接靶向YY1。随后,transwell实验、伤口愈合实验和裸鼠移植瘤模型证明YY1可以促进肺癌细胞的转移,而miR-142-5p在体外和体内削弱了YY1对肺癌细胞转移能力的刺激作用。westernblot和EMT相关蛋白的实时定量聚合酶链反应分析表明,YY1可以通过促进EMT而增强肺癌细胞的转移能力。相反,miR-142-5p通过靶向YY1抑制间充质标记物的表达,逆转细胞向间充质细胞的分化,削弱肿瘤细胞在体内外的转移能力。总之,miR-142-5p可能通过靶向YY1调节EMT相关蛋白的表达,从而抑制肺癌转移,这为肺癌提供了一个有希望的治疗靶点。

著录项

  • 来源
    《Cellular reprogramming》 |2020年第6期|共9页
  • 作者单位

    Xinjiang Med Univ Tumor Hosp Dept Thorac Oncol Affiliated Hosp 3 789 East Suzhou St Urumqi 830011 Peoples R China;

    Ili Kazakh Autonomous Prefecture State Friendship Dept Tumor Radiotherapy Yining Peoples R China;

    People Liberat Army 69260 Troops Med Team Outpatient Dept Urumqi Peoples R China;

    Xinjiang Med Univ Tumor Hosp Dept Thorac Oncol Affiliated Hosp 3 789 East Suzhou St Urumqi 830011 Peoples R China;

    Xinjiang Med Univ Tumor Hosp Dept Thorac Oncol Affiliated Hosp 3 789 East Suzhou St Urumqi 830011 Peoples R China;

    Xinjiang Med Univ Tumor Hosp Dept Thorac Oncol Affiliated Hosp 3 789 East Suzhou St Urumqi 830011 Peoples R China;

    Xinjiang Med Univ Tumor Hosp Dept Thorac Oncol Affiliated Hosp 3 789 East Suzhou St Urumqi 830011 Peoples R China;

    Xinjiang Med Univ Gen Dept Affiliated Hosp 3 Area 1 789 East Suzhou St Urumqi 830011 Peoples R China;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 分子生物学;
  • 关键词

    miR-142-5p; Yin Yang 1; epithelialamp; 8211; mesenchymal transition; lung cancer;

    机译:mir-142-5p;阴阳1;上皮&8211;间充质转换;肺癌;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号